Ahmed A Zeeneldin
Overview
Explore the profile of Ahmed A Zeeneldin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Ghafari A, Al Qahtani A, Alturki S, Al Doghaither H, Elmorsy E, Tashkandi H, et al.
Oncol Lett
. 2020 Sep;
20(5):155.
PMID: 32934723
Multidrug resistance member 1 (MDR1) is located on chromosome 7 and encodes P-glycoprotein, which is universally accepted as a drug resistance biomarker. polymorphisms can alter protein expression or function, which...
2.
Ali H, Emam A, Zeeneldin A, Srour R, Tabashy R, El-Desouky E, et al.
Clin Biochem
. 2019 Jan;
65:45-52.
PMID: 30653948
Background: A number of hepatocellular carcinoma (HCC) patients have developed resistance against transcatheter arterial chemoembolization (TACE) treatment. In this study, we aimed to develop a panel of microRNAs (miRs) biomarkers...
3.
Elserafi M, Zeeneldin A, Abdelsalam I, Nassar H, Moneer M, Buhoush W
J Egypt Natl Canc Inst
. 2018 Feb;
30(1):13-20.
PMID: 29428373
Introduction: Breast cancer (BC) is the commonest cancer among females worldwide. Some patients present initially at advanced stages and more than 50% of them will develop metastasis (MBC) at some...
4.
Zeeneldin A, Taha F
J Adv Res
. 2016 Feb;
7(1):37-45.
PMID: 26843968
Registering clinical trials (CTs) in public domains enhances transparency, increases trust in research, improves participation and safeguards against publication bias. This work was done to study the profile of clinical...
5.
Nassar H, Zeeneldin A, Helal A, Ismail Y, Elsayed A, Elbassuiony M, et al.
Asian Pac J Cancer Prev
. 2015 Oct;
16(16):7237-42.
PMID: 26514517
Background: Epithelial ovarian cancer (EOC) is the commonest malignancy involving the ovaries. Maximum surgical cytoreduction (MCR) followed by adjuvant taxane-platinum chemotherapy are the standard of care treatments. Aims: To study...
6.
El-Halawany M, Ismail H, Zeeneldin A, Elfiky A, Tantawy M, Kobaisi M, et al.
Biomed Res Int
. 2015 Mar;
2015:649750.
PMID: 25811030
Hepatocellular carcinoma (HCC) is a lethal malignancy with poor prognosis and limited treatment options. Transarterial chemoembolization (TACE) using chemotherapy agents-doxorubicin and cisplatin-is an accepted treatment option for locally advanced hepatocellular...
7.
Elgohary N, Pellegrino R, Neumann O, Elzawahry H, Saber M, Zeeneldin A, et al.
Int J Oncol
. 2014 Nov;
46(2):597-606.
PMID: 25405317
The mammalian timeless (TIM) protein interacts with proteins of the endogenous clock and essentially contributes to the circadian rhythm. In addition, TIM is involved in maintenance of chromosome integrity, growth...
8.
Zeeneldin A, Taha F
Qatar Med J
. 2014 Oct;
2014(1):31-7.
PMID: 25320690
Background: The aim of this work was to analyse the past trends of biomedical and cancer publications from Qatar listed on PubMed for the years 2000-2012. These findings were then...
9.
Zeeneldin A, Ramadan H, El Gammal M, Saber M, Elgamal D, Sherisher M
J Egypt Natl Canc Inst
. 2014 Aug;
26(3):127-37.
PMID: 25150128
Background And Aims: To study the clinico-pathological features, treatments and outcomes of gastric carcinoma (GC) in the elderly (⩾65 years) and the non-elderly Egyptian patients. Methods: This retrospective cohort study...
10.
Saber M, Zeeneldin A, El Gammal M, Salem S, Darweesh A, Abdelaziz A, et al.
J Egypt Natl Canc Inst
. 2014 May;
26(2):103-8.
PMID: 24841162
Introduction: Female germ cell tumors (GCTS) are rare tumors that carry a good prognosis. Aim: To report the experience of the Egyptian National Cancer Institute (ENCI) in managing female GCTs....